You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 6, June 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Endocrine Surgery
 •Alert me on articles by topic

Critical Analysis of a Large Series of Pancreaticogastrostomy After Pancreaticoduodenectomy

Gerard V. Aranha, MD, FRCSC; Joshua M. Aaron, BS; Margo Shoup, MD

Arch Surg. 2006;141:574-580.

Hypothesis  Pancreaticogastrostomy is a safe operation for a variety of periampullary conditions.

Design  Retrospective review of a prospectively collected database.

Setting  An academic tertiary care university hospital and a Veterans Affairs hospital.

Patients  A total of 235 consecutive patients who underwent pancreaticogastrostomy.

Main Outcome Measures  Indications for surgery, preoperative risk factors, intraoperative and postoperative variables, and factors that affect postoperative complications.

Results  The most common initial symptoms were jaundice (73.2%), weight loss (23.8%), and abdominal pain (17.0%). The 4 most common indications for surgery were pancreatic adenocarcinoma (41.3%), ampullary carcinoma (17.0%), duodenal carcinoma (7.2%), and chronic pancreatitis (7.2%). The median operating time was 6.5 hours. Median blood loss was 900 mL. The median intraoperative blood transfusion was 0 U. The median postoperative length of stay was 9 days. Postoperative mortality was 0.9%. The most common complications were pancreatic fistulae (13.6%), 1 of which was thought to cause 1 of 2 mortalities in this series. Pancreatic fistulae developing after pancreaticogastrostomy were significantly related to a low preoperative alkaline phosphatase level and surgery for nonpancreatic pathologic findings. The presence of a fistula significantly increased the postoperative length of hospital stay.

Conclusions  Pancreaticogastrostomy is a safe operation associated with low mortality and morbidity rates and a pancreatic fistula rate of 13.6%. It should be considered as a suitable alternative for management of the pancreatic remnant after pancreaticoduodenectomy.


Author Affiliations: Division of Surgical Oncology, Department of Surgery, Loyola University, Stritch School of Medicine, Maywood, Ill (Drs Aranha and Shoup and Mr Aaron), and Surgical Service, Hines VA Hospital, Hines, Ill (Dr Aranha).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Implications and Management of Pancreatic Fistulas Following Pancreaticoduodenectomy: The Massachusetts General Hospital Experience
Veillette et al.
Arch Surg 2008;143:476-481.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.